Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Revolution Medicines, Inc.
Seagen Inc.
Eli Lilly and Company
Pfizer
City of Hope Medical Center
Novartis
City of Hope Medical Center
Tempus AI